This inventor holds 4 USPTO granted patents. Top assignee: Massachusetts Institute of Technology. Active years: 1996-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-2001
Title: The Innovative Contributions of Roger M Nitsch
Introduction
Roger M Nitsch is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of neuroscience, particularly in understanding and treating diseases related to amyloid precursor protein processing. With a total of 4 patents, his work has the potential to impact the treatment of Alzheimer's disease and other related conditions.
Latest Patents
Nitsch's latest patents include groundbreaking methods for identifying agents that regulate the release of amyloid precursor protein (APP). One of his notable inventions describes an assay for testing agents that can stimulate the secretion of APP. This method is particularly useful for treating and preventing diseases involving APP processing, such as Alzheimer's disease. Another patent focuses on stimulating non-amyloidogenic processing of amyloid by activating cell surface serotonin receptors. This activation can be achieved through agents that act as serotonin agonists or increase the intrasynaptic concentration of serotonin. These innovations aim to inhibit the deposition of amyloid in the brain, offering new avenues for treatment.
Career Highlights
Roger M Nitsch is affiliated with the Massachusetts Institute of Technology, where he continues to advance research in his field. His work has garnered attention for its potential to change the landscape of Alzheimer's disease treatment.
Collaborations
Nitsch has collaborated with notable colleagues, including Richard J Wurtman and John H Growdon. Their combined expertise has contributed to the development of innovative solutions in neuroscience.
Conclusion
Roger M Nitsch's contributions to the field of neuroscience through his patents and research are invaluable. His work not only enhances our understanding of amyloid precursor protein processing but also paves the way for potential treatments for Alzheimer's disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
